Safety of Switching From Rituximab to Ocrelizumab in MS Patients

Clinical trial NCT02980042 · COMPLETED

Trial details

NCT number: NCT02980042
Sponsor: University of Colorado, Denver
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2017-01-01
Primary completion: 2019-03-06
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.